EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Role of 11-Oxygenated Androgens and Endocrine Disruptors in Androgen Excess Disorders in Women

Jana Vitku iD, Anezka Varausova iD, Tereza Skodova iD, Lucie Kolatorova iD, Michala Vosatkova, Josef Vcelak iD, Jana Vrbikova, Marketa Simkova iD, Michaela Svojtkova iD

International Journal of Molecular Sciences · 07.09.2024 · 25 (17) · 9691

DOI: 10.3390/ijms25179691 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 07.09.2024. Verfasst von Jana Vitku und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Steroids and Proteofactors, Institute of Endocrinology, Narodni 8, 116 94 Prague, Czech Republic. Hauptthemen laut MEDLINE: Polycystic Ovary Syndrome, Androgens, Endocrine Disruptors, Hirsutism. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Health of the Czech Republic - DRO, MH CZ—DRO, Institute of Endocrinology EÚ.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Polycystic ovary syndrome (PCOS) and idiopathic hirsutism (IH) are androgen excess disorders requiring the determination of classic androgen levels for diagnosis. 11-oxygenated androgens have high androgenic potential, yet their clinical value in those disorders is not clear. Additionally, the role of endocrine disruptors (EDs), particularly in IH, remains understudied. We analyzed 25 steroids and 18 EDs in plasma samples from women with IH, PCOS, and controls using LC-MS/MS. Cytokine levels and metabolic parameters were assessed. Comparisons included non-obese women with PCOS (n = 10), women with IH (n = 12) and controls (n = 20), and non-obese versus obese women with PCOS (n = 9). Higher levels of 11-oxygenated androgens were observed in women with PCOS compared to those with IH, but not controls. Conversely, 11-oxygenated androgen levels were lower in women with IH compared to controls. Cytokine levels did not differ between women with IH and controls. Bisphenol A (BPA) levels were higher in obese women with PCOS compared to non-obese women with PCOS. Bisphenol S occurrence was higher in women with PCOS (90%) compared to controls (65%) and IH (50%). Significant correlations were found between androgens (11-ketotestosterone, androstenedione, testosterone) and insulin and HOMA-IR, as well as between immunomodulatory 7-oxygenated metabolites of DHEA and nine interleukins. Our data confirms that PCOS is a multiendocrine gland disorder. Higher BPA levels in obese women might exacerbate metabolic abnormalities. IH was not confirmed as an inflammatory state, and no differences in BPA levels suggest BPA does not play a role in IH pathogenesis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Polycystic Ovary SyndromeAndrogensEndocrine DisruptorsHirsutismHumansFemaleAdultObesityCytokinesTandem Mass SpectrometryBenzhydryl CompoundsHyperandrogenismPhenolsYoung AdultBisphenol A Compounds

Stichwörter der Autor:innen

11-hydroxytestosterone11-ketotestosterone11-oxygenated androgenbisphenol Abisphenol Sendocrine disruptoridiopathic hirsutismpolycystic ovary syndrome

Substanzen

AndrogensEndocrine DisruptorsCytokinesBenzhydryl CompoundsPhenolsbisphenol ABisphenol A Compounds

Autor:innen und Institutionen

  • Department of Steroids and Proteofactors, Institute of Endocrinology, Narodni 8, 116 94 Prague, Czech Republic.
  • Department of Clinical Biochemistry, Institute of Endocrinology, Narodni 8, 116 94 Prague, Czech Republic.
  • Department of Molecular Endocrinology, Institute of Endocrinology, Narodni 8, 116 94 Prague, Czech Republic.
  • Department of Clinical Endocrinology, Institute of Endocrinology, Narodni 8, 116 94 Prague, Czech Republic.

ORCID-Profile: Jana Vitku, Anezka Varausova, Tereza Skodova, Lucie Kolatorova, Josef Vcelak, Marketa Simkova, Michaela Svojtkova

Förderung

  • Ministry of Health of the Czech Republic - DRO
  • MH CZ—DRO, Institute of Endocrinology EÚ

Zitieren

APA

Vitku, J., Varausova, A., Skodova, T., Kolatorova, L., Vosatkova, M., Vcelak, J., Vrbikova, J., Simkova, M., & Svojtkova, M. (2024). The Role of 11-Oxygenated Androgens and Endocrine Disruptors in Androgen Excess Disorders in Women. International Journal of Molecular Sciences, 25(17), 9691. https://doi.org/10.3390/ijms25179691

Vancouver

Vitku J, Varausova A, Skodova T, Kolatorova L, Vosatkova M, Vcelak J, et al. The Role of 11-Oxygenated Androgens and Endocrine Disruptors in Androgen Excess Disorders in Women. International Journal of Molecular Sciences. 2024;25(17):9691. doi:10.3390/ijms25179691

BibTeX
@article{Vitku2024,
  author = {Vitku, Jana and Varausova, Anezka and Skodova, Tereza and Kolatorova, Lucie and Vosatkova, Michala and Vcelak, Josef and Vrbikova, Jana and Simkova, Marketa and Svojtkova, Michaela},
  title = {The Role of 11-Oxygenated Androgens and Endocrine Disruptors in Androgen Excess Disorders in Women},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  volume = {25},
  number = {17},
  pages = {9691},
  doi = {10.3390/ijms25179691}
}
Kostenlos starten →